Long-Term SGRQ Stability in a Cohort of Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

References

• Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434):613–620. doi:10.1016/S0140-6736(04)16855-4
   PubMed Web of Science ®Google Scholar
• Sandhaus RA, Turino G, Brantly ML, et al. The diagnosis and management of alpha-1 antitrypsin deficiency in the adult. Chronic Obstr Pulm Dis. 2016;3(3):668. doi:10.15326/jcopdf.3.3.2015.0182
   PubMed Web of Science ®Google Scholar
• Eden E. Asthma and COPD in alpha-1 antitrypsin deficiency. evidence for the Dutch hypothesis. COPD. 2010;7(5):366–374. doi:10.3109/15412555.2010.510159
   PubMedGoogle Scholar
• Zamzam MA, Azab NY, El Wahsh RA, Ragab AZ, Allam EM. Quality of life in COPD patients. Egypt J Chest Dis Tuberculosis. 2012;61(4):281–289. doi:10.1016/j.ejcdt.2012.08.012
   Google Scholar
• Jones P, Wijkstra PJ. Quality of life in patients with chronic obstructive pulmonary disease. Europ Respir Monograph. 2006;38:375.
   Google Scholar
• Ståhl E, Lindberg A, Jansson S-A, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005;3(1):1–8. doi:10.1186/1477-7525-3-56
   PubMedGoogle Scholar
• Jenkins C, Rodriguez-Roisin R. Quality of life, stage severity and COPD. Eur Respir Soc. 2009;33(5):953–955. doi:10.1183/09031936.00019009
   Web of Science ®Google Scholar
• Campos MA, Alazemi S, Zhang G, Wanner A, Sandhaus RA. Effects of a disease management program in individuals with alpha-1 antitrypsin deficiency. COPD. 2009;6(1):31–40. doi:10.1080/15412550802607410
   PubMedGoogle Scholar
• Holm KE, Borson S, Sandhaus RA, et al. Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD. COPD. 2013;10(2):226–234. doi:10.3109/15412555.2012.719049
   PubMedGoogle Scholar
• Kwon H-Y, Kim E. Factors contributing to quality of life in COPD patients in South Korea. Int J Chronic Obstr. 2016;103–109. doi:10.2147/COPD.S90566
   PubMedGoogle Scholar
• Lazarus RS, DeLongis A. Psychological stress and coping in aging. Am Psychologist. 1983;38(3):245. doi:10.1037/0003-066X.38.3.245
   Web of Science ®Google Scholar
• Holm KE, Plaufcan MR, Ford DW, et al. The impact of age on outcomes in chronic obstructive pulmonary disease differs by relationship status. J Behav Med. 2014;37(4):654–663. doi:10.1007/s10865-013-9516-7
   PubMed Web of Science ®Google Scholar
• Choate R, Holm KE, Sandhaus RA, Mannino DM, Strange C. Health-related Quality of Life in alpha-1 antitrypsin deficiency-associated COPD. Am J Respir Crit Care Med. 2023;208(ja):1132–1134. doi:10.1164/rccm.202304-0697LE
   PubMedGoogle Scholar
• Alphas Serving Alphas. AlphaNet. Avialable frome: https://www.alphanet.org/. Accessed december 15, 2022.
   Google Scholar
• Jones P, Quirk F, Baveystock C.The St George’s Respiratory Questionnaire. Respir Med.1991;85:25–31. doi:10.1016/S0954-6111(06)80166-6
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.1321
   PubMed Web of Science ®Google Scholar
• Williams N. The MRC breathlessness scale. Occup Med. 2017;67(6):496–497. doi:10.1093/occmed/kqx086
   Google Scholar
• Pinheiro JC, Bates DM. Linear mixed-effects models: basic concepts and examples. Mixed Effects Models S S-Plus. 2000;3–56.
   Google Scholar
• Schielzeth H, Dingemanse NJ, Nakagawa S, et al. Robustness of linear mixed‐effects models to violations of distributional assumptions. Meth Ecol Evolut. 2020;11(9):1141–1152. doi:10.1111/2041-210X.13434
   Web of Science ®Google Scholar
• Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med. 2007;101(1):146–153. doi:10.1016/j.rmed.2006.04.001
   PubMed Web of Science ®Google Scholar
• Ferrari R, Tanni SE, Caram LM, Naves CR, Godoy I. Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2011;9(1):1–10. doi:10.1186/1477-7525-9-112
   Google Scholar
• Dowson LJ, Guest PJ, Stockley RA. Longitudinal changes in physiological, radiological, and health status measurements in α1-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med. 2001;164(10):1805–1809. doi:10.1164/ajrccm.164.10.2106036
   Web of Science ®Google Scholar
• Stolk J, Ng W, Bakker M, et al. Correlation between annual change in health status and computer tomography derived lung density in subjects with α1-antitrypsin deficiency. Thorax. 2003;58(12):1027. doi:10.1136/thorax.58.12.1027
   PubMed Web of Science ®Google Scholar
• Cannon D, Buys N, Sriram KB, Sharma S, Morris N, Sun J. The effects of chronic obstructive pulmonary disease self-management interventions on improvement of quality of life in COPD patients: a meta-analysis. Respir Med. 2016;121:81–90. doi:10.1016/j.rmed.2016.11.005
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422. doi:10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• Ferrari R, Tanni SE, Lucheta PA, Faganello MM, RAFd A, Godoy I. Gender differences in predictors of health status in patients with COPD. J Bras Pneumol. 2010;36(1):37–43. doi:10.1590/S1806-37132010000100008
   PubMed Web of Science ®Google Scholar
• Martinez CH, Diaz AA, Parulekar AD, et al. Age-related differences in health-related quality of life in COPD: an analysis of the COPDGene and SPIROMICS cohorts. Chest. 2016;149(4):927–935. doi:10.1016/j.chest.2015.11.025
   PubMed Web of Science ®Google Scholar
• Hynninen MJ, Pallesen S, Nordhus IH. Factors affecting health status in COPD patients with co-morbid anxiety or depression. Int J Chron Obstruct Pulmon Dis. 2007;2(3):323.
   PubMedGoogle Scholar
• Ekici A, Bulcun E, Karakoc T, Senturk E, Ekici M. Factors associated with quality of life in subjects with stable COPD. Respir Care. 2015;60(11):1585–1591. doi:10.4187/respcare.03904
   PubMed Web of Science ®Google Scholar
• Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am j Med. 2006;119(10):12–20. doi:10.1016/j.amjmed.2006.08.003
   PubMed Web of Science ®Google Scholar
• Justine M, Tahirah F, Mohan V. Health-related quality of life, lung function and dyspnea rating in COPD patients. Monaldi Arch Chest Disease. 2013;79(3–4). doi:10.4081/monaldi.2013.5209
   PubMedGoogle Scholar
• Jones PW, Anderson JA, Calverley PM, et al. Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res. 2011;12(1):1–8. doi:10.1186/1465-9921-12-71
   PubMedGoogle Scholar
• Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554. doi:10.1056/NEJMoa0805800
   PubMed Web of Science ®Google Scholar
• Vasakova M, Sterclova M, Moğulkoç N, et al. Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries. Eur Respir Soc. 2021.
   Google Scholar
• Elston DM. Survivorship bias. European Respiratory Journal. 2021; 58: PA477. doi:10.1183/13993003.congress-2021.PA477
   Google Scholar